Addyi was very first permitted via the FDA in August 2015 to take care of hypoactive sexual desire condition (HSDD) in premenopausal Females. That is just another way of claiming it boosts sexual intercourse travel (also known as libido) in Women of all ages who have not reached menopause. It was the first this kind of drug authorized for this use.